Cialis online Cialis online viagra online
Popular Tags
Add new tag Agriculture allele Antarctica atmosphere Bacteria Biodiversity biofuels biological Biology biotechnology blood cancer carbon carbon dioxide cell cells chemistry cholesterol climate Climate change CO2 CO2 emissions computer science diabetes disease Diseases DNA education electrical engineering electricity emission emissions Energy engineering environmental environmental protection Environment and Environmental Quality Food gene genetic mutation Genetics geologist global warming Health and Medicine HIV Hydrogen hypothesis IBM immunology influenza information information technology lasers LHC life sciences lung cancer mathematician mathematics mechanisms Meteorology Microorganisms Molecular molecule molecules nanoscience Nanotechnology nasa Natural Sciences Oceanography organism oxygen phenomenon photovoltaic cells physicist physicists Physics power Professional Profile protein proteins Renewable energy Research Researchers RNA satellite Science scientist Scientists semiconductor Solar energy species Stem cells Technology Telecommunications temperature tissue vaccine virus wind energy

Developments for generics in Japan

e13The Japanese Generic Pharmaceutical Manufacturers Association (JGPMA), which includes forty pharmaceutical companies, has published a list comparing the effectiveness of generic drugs produced by its members to the corresponding medicines. This is primarily to inform and reassure the public, which seems to feel some confidence in generics, as was shown in two studies conducted in 2006, one with health professionals, the other with the general population. At the time, 2 / 3 of the doctors interviewed had expressed "skepticism" or "cautious" about the effectiveness of generic, many claimed that their patients complained of lower effectiveness and a lack of information

from the companies that manufacture them. Only a small minority among the respondents from the second study had previously used this type of medication. The other had not heard of or use of preferred brand-name drugs. With a total value of approximately $ 80 billion, the Japanese pharmaceutical market is the second in the world. According to the JGPMA in 2006, the share of generic drugs amounted to 5.7% of the total value and about 17% of market volume. This share is expected to double in 5 years, because the Ministry of Finance announced in 2007 a plan to promote the use of generic drugs to deal with rising health costs. It should be noted that the Israeli company Teva, a world leader in the production of generics, is considering creating a joint venture with Kowa Pharma Ltd., Japanese pharmaceutical company. The Teva-Kowa Pharma, which should be launched in 2009, is to reach one billion dollars in sales by 2015.

Leave a Reply

You can use these XHTML tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>